Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14230
Abstract: Direct oral anticoagulants (DOACs) have predictable pharmacokinetics and are licensed for stroke prevention in non-valvular atrial fibrillation (SPAF) and the treatment and secondary prevention of venous thromboembolism (VTE) without the need for monitoring. However there… read more here.
Keywords: coagulation; routine coagulation; rivaroxaban; commonly used ... See more keywords